What is Medable?
Headquartered in Palo Alto, California, Medable operates at the intersection of clinical research and digital transformation. The company provides a comprehensive platform designed to facilitate decentralized clinical trials, enabling researchers to capture real-time patient data with greater precision and efficiency. By integrating predictive medicine capabilities and patient-centric digital tools, Medable addresses the systemic inefficiencies inherent in traditional trial models. Its market position is defined by its ability to scale enterprise-level operations, effectively reducing the time and cost associated with bringing life-saving therapies to market while enhancing the overall participant experience.
How much funding has Medable raised?
Medable has raised a total of $518.8M across 6 funding rounds:
Series A
$3.6M
Series B
$16.2M
Debt
$1M
Other Financing Round
$25M
Series C
$169M
Series D
$304M
Series A (2015): $3.6M, investors not publicly disclosed
Series B (2018): $16.2M, investors not publicly disclosed
Debt (2020): $1M supported by PPP
Other Financing Round (2020): $25M featuring GSR Ventures and PPD, Inc
Series C (2021): $169M backed by GSR Ventures, The Obvious, Streamline Ventures, PPD Group Inc, and Sapphire Ventures LLC
Series D (2021): $304M with participation from WTI - Western Telematic, GSR Ventures, Blackstone Accelerates Growth, Sapphire Ventures, and Tiger Global Management
Key Investors in Medable
Sapphire Ventures
Sapphire Ventures is a venture capital firm focused on investing in and providing services to technology companies, leveraging deep industry expertise to scale high-growth enterprises.
Tiger Global Management
Tiger Global Management is a prominent investment firm that deploys capital across both public and private markets, with a strong track record of backing transformative technology companies.
Blackstone Accelerates Growth
Blackstone Accelerates Growth (BxG) is an initiative focused on driving economic development and supporting the next generation of innovative companies through strategic partnerships and focused growth activities.
What's next for Medable?
With the successful completion of its latest financing round, Medable is well-positioned to expand its global footprint and deepen its technological moat. The company is expected to prioritize the enhancement of its predictive analytics engine and the integration of more diverse data streams to support increasingly complex therapeutic areas. As the industry shifts toward hybrid and decentralized research methodologies, Medable's strategic focus will likely center on maintaining regulatory compliance at scale, fostering deeper partnerships with global clinical research organizations, and continuing to innovate within the precision medicine landscape to maintain its competitive advantage in a rapidly evolving healthcare ecosystem.
See full Medable company page
